Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gemcitabine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03587662
What this trial is testing

Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Metastatic Kidney Medullary CarcinomaMetastatic Renal Cell CarcinomaSMARCB1 Negative+2 more
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00161213
What this trial is testing

Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Medicine and Dentistry of New Jersey 44
Early research (Phase 1)Study completedNCT00556023
What this trial is testing

Study Testing CP-675,206 In Combination With Gemcitabine In Patients With Previously Untreated, Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
AstraZeneca 37
Early research (Phase 1)Study completedNCT02272738
What this trial is testing

Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Osaka Medical Center for Cancer and Cardiovascular Diseases 54
Testing effectiveness (Phase 2)WithdrawnNCT00253526
What this trial is testing

Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage I Pancreatic Cancer+2 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT05074589
What this trial is testing

Irinotecan Liposome in Combination With 5-FU/LV Versus 5-FU/LV in Second-line Therapy for Gemcitabine-Refractory Pancreatic Cancer

Who this might be right for
Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based Therapy
Jiangsu HengRui Medicine Co., Ltd. 298
Testing effectiveness (Phase 2)Study completedNCT00407550
What this trial is testing

Pemetrexed Disodium and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Mayo Clinic 19
Large-scale testing (Phase 3)Not Yet RecruitingNCT07691515
What this trial is testing

Intraarterial Therapies Plus Tislelizumab Plus Lenvatinib Versus Tislelizumab Plus Gemcitabine-Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Zhejiang Cancer Hospital 140
Early research (Phase 1)Study completedNCT02227940
What this trial is testing

Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmALK PositiveMetastatic Pancreatic Adenocarcinoma+2 more
Roswell Park Cancer Institute 38
Testing effectiveness (Phase 2)Study completedNCT00193050
What this trial is testing

Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
SCRI Development Innovations, LLC 110
Testing effectiveness (Phase 2)UnknownNCT01222676
What this trial is testing

Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the Bladder

Who this might be right for
Bladder Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 45
Testing effectiveness (Phase 2)Study completedNCT03464968
What this trial is testing

MFOLFOX vs. mFOLFIRI in Advanced or Recurrent Biliary Tract Cancer Refractory to First Line

Who this might be right for
Biliary Cancer Metastatic
Seoul National University Bundang Hospital 120
Not applicableStudy completedNCT00283478
What this trial is testing

Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Kentuckiana Cancer Institute 20
Not applicableStudy completedNCT05374876
What this trial is testing

Hand Therapy Intervention Versus Traditional Occupational Therapy to Prevent Chemotherapy Induced Peripheral Neuropathy

Who this might be right for
Adenocarcinoma of Pancreas
HonorHealth Research Institute 49
Early research (Phase 1)Study completedNCT00066768
What this trial is testing

Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)Study completedNCT00033735
What this trial is testing

Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Eisai Inc. 158
Testing effectiveness (Phase 2)UnknownNCT03311789
What this trial is testing

Study of PD-1 Inhibitor in Combination With Gemcitabine/Cisplatin for Advancer BTCs

Who this might be right for
Biliary Tract Cancer
Chinese PLA General Hospital 30
Large-scale testing (Phase 3)UnknownNCT02207335
What this trial is testing

Trial of Gemcitabine_Capecitabine Versus Gemcitabine_Carboplatin in Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 120
Testing effectiveness (Phase 2)Study completedNCT03123276
What this trial is testing

Pembrolizumab and Gemcitabine Chemotherapy in Leiomyosarcoma and Undifferentiated Pleomorphic Sarcoma

Who this might be right for
Sarcoma
Royal Marsden NHS Foundation Trust 25
Testing effectiveness (Phase 2)Study completedNCT00080795
What this trial is testing

Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
M.D. Anderson Cancer Center 65
Next Page